This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Evaluation At UK Deployed Field Hospital Demonstrates Advantages Of Vision-Sciences' EndoSheath(R) Technology For Bronchoscopy

Stocks in this article: VSCI

ORANGEBURG, N.Y., Sept. 9, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath ® technology, today announced positive results from a three-month evaluation completed in 2012 by the British Army at Camp Bastion, a deployed field hospital in Afghanistan. The research evaluated the efficacy and utility of our flexible bronchoscope with EndoSheath technology and its rapid, simplified cleaning routine versus conventional bronchoscopes, which require specialized, complicated disinfection processes between each use.

The abstract, entitled " Evaluation of a disposable sheath bronchoscope system for use in the deployed field hospital," was published first online on August 28, 2013, in J R Army Med Corps. Study authors Lieutenant Colonel Andrew McDonald Johnston et al concluded that a disposable single-use sheath reduces the risk of cross-contamination and avoids the need for prolonged liquid immersion, sterilization or the increased cost of completely disposable single-use bronchoscopes. Furthermore, they found that a bronchoscope system that can be cleaned without sending it out of the deployed hospital alleviated physicians' concern regarding availability and should therefore be part of the equipment table in the field hospital. Complex endoscope sterilization systems required to ensure adequate cleaning and sterility of bronchoscopes are not part of the equipment found at a deployed UK field hospital. After use, these systems have to be sent to another facility, and the round trip, including sterilization, typically takes 1-3 days, creating a potential risk of not having a bronchoscope available at short notice.

In a deployed environment, bronchoscopy can play an important role when caring for patients who have suffered penetrating trauma as they often develop complications, such as bleeding from the airways, mucus plugging, and pulmonary infections. The three physicians who used the scope ten times during the three-month period of evaluation were all experienced in bronchoscopy, including two pulmonary and critical care physicians and one anesthetic trained intensivist. The EndoSheath technology was used predominantly in patients with high velocity fragment or bullet wounds to the thorax to clear blood from the airways. In one instance, this was found to be life-saving, and in another, it significantly shortened the length of time for ventilation and allowed early extubation. The system also demonstrated its utility in performing percutaneous tracheostomy.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,327.11 +135.74 0.79%
S&P 500 2,008.92 +6.76 0.34%
NASDAQ 4,650.4890 +12.4950 0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs